Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

1 Tech Stock to Buy and 1 to Avoid


Tech stocks have generally done well this year, staging a solid recovery from a tough 2022. But not all tech stocks are created equal. AT (NYSE: T) looks like a bargain, while Apple (NASDAQ: AAPL) looks severely overpriced.

There are two core reasons to invest in AT stock: The valuation and the dividend. The stock price reflects an extreme amount of pessimism that looks overdone, and the dividend, while unlikely to grow quickly, has a sky-high yield.

AT expects to generate AT least $16 billion of free cash flow this year despite a slower pace of wireless subscriber additions. With a market capitalization of $114 billion, the stock trades for roughly 7 times free cash flow. That looks like a bargain.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,047 €
-1,05 %
Allergy Therapeutics PLC muss heute Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -1,05 % tiefer.

Like: 0
T
Teilen

Kommentare